Skip to main content
Signal8

Lizzul Paul F.

SEC insider (Form 3/4/5 filer). CIK 0001711462. Chief Medical Officer at First Tracks Biotherapeutics, Inc. (TRAX) and 1 other issuer. 36 reported Form 4/5 transactions since Sep 2024; latest on Aug 15, 2026. Located in SAN DIEGO, CA.

Companies Lizzul Paul F. has filed insider reports for

  • First Tracks Biotherapeutics, Inc. (TRAX): Officer, Chief Medical Officer
  • ANAPTYSBIO, INC (ANAB): Officer, Chief Medical Officer
Lizzul Paul F. profile photo

Lizzul Paul F.

CIK: 0001711462

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)6 (16.7%)

Position reduction

Option Exercises (M)8 (22.2%)

Derivative conversions

Awards (A)20 (55.6%)

Compensation grants

Other (G, F, J, C, D, …)2 (5.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

First Tracks Biotherapeutics, Inc. logo
TRAX

First Tracks Biotherapeutics, Inc.

Officer
ANAPTYSBIO, INC logo
ANAB

ANAPTYSBIO, INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (36 total)

  • First Tracks Biotherapeutics, Inc. logo
    TRAX

    First Tracks Biotherapeutics, Inc.

    Aug 15, 2026
    Award

    Performance Stock Units

    Direct
    60.5K shares-
  • First Tracks Biotherapeutics, Inc. logo
    TRAX

    First Tracks Biotherapeutics, Inc.

    Aug 2, 2026
    Award

    Performance Stock Units

    Direct
    60.5K shares-
  • First Tracks Biotherapeutics, Inc. logo
    TRAX

    First Tracks Biotherapeutics, Inc.

    May 12, 2026
    Award

    Restricted Stock Unit

    Direct
    26.7K shares-
  • First Tracks Biotherapeutics, Inc. logo
    TRAX

    First Tracks Biotherapeutics, Inc.

    May 12, 2026
    Award

    Employee Stock Option (right to buy)

    Direct
    72.3K shares-
  • First Tracks Biotherapeutics, Inc. logo
    TRAX

    First Tracks Biotherapeutics, Inc.

    Apr 20, 2026
    Award

    Stock Option (right to buy)

    Direct
    97.2K shares-
  • First Tracks Biotherapeutics, Inc. logo
    TRAX

    First Tracks Biotherapeutics, Inc.

    Apr 20, 2026
    Award

    Stock Option (right to buy)

    Direct
    83.5K shares-
  • First Tracks Biotherapeutics, Inc. logo
    TRAX

    First Tracks Biotherapeutics, Inc.

    Apr 20, 2026
    Award

    Stock Option (right to buy)

    Direct
    29K shares-
  • First Tracks Biotherapeutics, Inc. logo
    TRAX

    First Tracks Biotherapeutics, Inc.

    Apr 20, 2026
    Award

    Stock Option (right to buy)

    Direct
    70K shares-
  • First Tracks Biotherapeutics, Inc. logo
    TRAX

    First Tracks Biotherapeutics, Inc.

    Apr 20, 2026
    Award

    Stock Option (right to buy)

    Direct
    67.1K shares-
  • First Tracks Biotherapeutics, Inc. logo
    TRAX

    First Tracks Biotherapeutics, Inc.

    Apr 20, 2026
    Award

    Stock Option (right to buy)

    Direct
    115.5K shares-

1-10 of 36